-
- Topic
- Voices
- Last Post
-
-
Adjuvant Ipi vs. Nivo
Started by:
in: Other
- 4
- January 31, 2018 at 8:37 pm
-
CNS Disease
Started by:
in: Side-effect management
- 4
- January 30, 2018 at 7:51 pm
-
? odd toxicity
Started by:
- 2
- January 27, 2018 at 11:50 pm
-
Dose reductions with BRAF/MEK inhibitors
Started by:
- 3
- January 22, 2018 at 11:28 pm
-
High copays
Started by:
- 2
- January 22, 2018 at 11:21 pm
-
PTSD in Melanoma
Started by:
- 2
- January 18, 2018 at 8:23 pm
-
Ocular herpes
Started by:
- 5
- January 5, 2018 at 2:54 am
-
Pre-existing rheumatologic conditions
Started by:
- 3
- January 5, 2018 at 2:50 am
-
Coordination with primary care
Started by:
- 3
- January 4, 2018 at 8:17 pm
-
Infusion reactions
Started by:
- 3
- December 24, 2017 at 4:11 pm
-
Pharmacy and nurse roles
Started by:
- 3
- December 24, 2017 at 4:06 pm
-
preparing patient for treatment
Started by:
- 3
- December 20, 2017 at 9:17 pm
-
Cardiac side effects of ICIs
Started by:
- 2
- December 20, 2017 at 8:28 pm
-
Diet and melanoma risk
Started by:
- 1
- December 20, 2017 at 4:43 pm
-
T-VEC purchasing
Started by:
- 1
- December 19, 2017 at 7:44 pm
-
Adjuvant Ipi vs. Nivo
Copyright ©2023- - The Melanoma Nursing Initiative. All rights reserved.